Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity
Daniel Ysselstein, Tiffany Young, Maria Nguyen, et al.
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2719-2730
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith, Anthony H.V. Schapira
Cells (2022) Vol. 11, Iss. 8, pp. 1261-1261
Open Access | Times Cited: 135
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Neal J. Weinreb, Özlem Göker-Alpan, Priya S. Kishnani, et al.
Molecular Genetics and Metabolism (2022) Vol. 136, Iss. 1, pp. 4-21
Open Access | Times Cited: 44
Glucocerebrosidase mutations and Parkinson disease
Sophia R.L. Vieira, Anthony H.V. Schapira
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 39
LRRK2 and Parkinson's disease: from genetics to targeted therapy
Yuri L. Sosero, Ziv Gan‐Or
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 6, pp. 850-864
Open Access | Times Cited: 31
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
A Biomarker Study in Patients with GBA1 ‐Parkinson's Disease and Healthy Controls
Jonas M. den Heijer, Valerie Cullen, D. Pereira, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 783-795
Open Access | Times Cited: 17
Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease
Zuzanna Cyske, Lidia Gaffke, Estera Rintz, et al.
Neurochemistry International (2024) Vol. 178, pp. 105774-105774
Closed Access | Times Cited: 6
Mechanisms of Glucocerebrosidase Dysfunction in Parkinson’s Disease
Diptaman Chatterjee, Dimitri Krainc
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168023-168023
Open Access | Times Cited: 15
Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity
Myung Jong Kim, Hyunkyung Jeong, Dimitri Krainc
Human Molecular Genetics (2022) Vol. 31, Iss. 14, pp. 2424-2437
Open Access | Times Cited: 22
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
Laura Smith, Chiao‐Yin Lee, Elisa Menozzi, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 22
A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells
Matthew C. Deen, Yanping Zhu, Christina Gros, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 29
Open Access | Times Cited: 19
Comparative analysis of methods for measuring glucocerebrosidase enzyme activity in patients with Parkinson’s disease with the GBA1 variant
Jin Hwangbo, Myung Jun Lee, Sang Jin Kim, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease
Lyudmila P. Dolgacheva, В. П. Зинченко, Н. В. Гончаров
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13043-13043
Open Access | Times Cited: 17
A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
Sha Zhu, Matthew C. Deen, Yanping Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 40
Open Access | Times Cited: 8
LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
Jasmin Galper, Woojin S. Kim, Nicolas Dzamko
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1597-1597
Open Access | Times Cited: 13
Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery
Ali Esfandiary, David I. Finkelstein, Nicolas H. Voelcker, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1353-1353
Open Access | Times Cited: 12
Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease
Darian Williams, Logan M. Glasstetter, Tiffany T. Jong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s disease
Darian Williams, Logan M. Glasstetter, Tiffany T. Jong, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Open Access | Times Cited: 2
LRRK2 exonic variants are associated with lysosomal hydrolase activities and lysosphingolipid alterations in Parkinson's disease
Tatiana Usenko, Konstantin Senkevich, Katerina Basharova, et al.
Gene (2023) Vol. 882, pp. 147639-147639
Closed Access | Times Cited: 5
Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
Adahir Labrador‐Garrido, Siying Zhong, Laura P. Hughes, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Identification of pyrimidinyl piperazines as non-iminosugar glucocerebrosidase (GCase) pharmacological chaperones
Tamaki Hoshikawa, Tôru Watanabe, Makoto Kotake, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 81, pp. 129130-129130
Open Access | Times Cited: 3
The Frequency of Korean Patients With Parkinson’s Disease Carrying GBA Mutations in a Subgroup With Age at Onset ≤ 55 Years Old
Jin Hwangbo, Myung Jun Lee, Sang Jin Kim, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 2, pp. 207-209
Open Access | Times Cited: 2
New Antibodies to Advance Glucocerebrosidase Research
Nicolas Dzamko
Journal of Parkinson s Disease (2024), pp. 1-2
Open Access
Functional Study of SNCA p.V15A Variant: Further Linking α‐Synuclein and Glucocerebrosidase
Micol Avenali, Silvia Cerri, Ilaria Palmieri, et al.
Movement Disorders (2024) Vol. 39, Iss. 6, pp. 1060-1065
Open Access
Direct and indirect regulation of β-glucocerebrosidase by the transcription factorsUSF2andONECUT2
Kathi Ging, Lukas Frick, Johannes C. M. Schlachetzki, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top